Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 39.2M | 47.1M | 78.6M | 46.8M | 72.8M | 34.0M | 2.9M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -349.4M | -261.6M | -165.5M | -161.3M | -100.5M | -46.3M | -42.2M |
| EBITDA | — | — | — | — | — | — | — |
| Net Income | -311.4M | -223.9M | -147.0M | -154.8M | -100.2M | -45.6M | -41.2M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 84M | 75M | 58M | 54M | 48M | 17M | 2M |
Kymera Therapeutics Inc. Income Statement — FAQ
Kymera Therapeutics Inc. (KYMR) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYMR's income statement history?
The chart and table above show Kymera Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.